Webinar replay
Pharma vs AI: Tackling the threat of misinformation
Apr 27, 2026
Datapharm and PharmaTimes welcomed attendees to a webinar session featuring leading pharmacy experts, offering an inside look into pharmacists’ use of genAI and the support they need from industry partners.
Healthcare professionals (HCPs) are being asked to do much more with much less time, under increasing pressure to access medicines information quickly, driving them to rapid answers from AI tools.
In this recent webinar hosted by PharmaTimes, our expert panel shared valuable insights into how AI is helping or hindering healthcare, and how Pharma can respond to this new pharmacy environment.
Key topics:
- AI misinformation in education: To what extent are genAI tools referencing trustworthy sources, and can these references even be trusted?
- AI (in)accuracy: In a live poll during the webinar, 67% of attendees said they found AI‑generated medicines information to be occasionally inaccurate, highlighting the ongoing need for trusted and reliable sources.
- Building trust through appropriate content: HCPs want to connect with Pharma to share experiences and improve how they receive medicines information content
Webinar replay
Pharma vs AI: Tackling the threat of misinformationWatch the webinar replay below for a deep dive into AI in clinical practice and education, HCPs' expectations of pharma, and the path forward.
Enabling the Life Sciences to deliver medicine safety information to HCPs with high efficiency, while maintaining robust compliance standards
Datapharm provides technology-enabled solutions to the global life sciences and wider healthcare sectors. Its mission is to improve the accessibility and effectiveness of medicine safety information – it is the provider of the electronic medicines compendium (emc), which started as a book in the 1970’s and continues to be well embedded in the healthcare setting today.
emc is the resource most trusted by medical professionals to provide accessible, up-to-date, regulated medicine information, including the Summary of Product Characteristics (SmPC), Patient Information Leaflet (PIL), and Risk Minimisation Materials (RMMs). Find out more about emc here.
Over 70 Life Science companies in the UK use their applications for maintaining high compliance standards: emc pi portal, which is helping companies save tens of thousands when updating and sharing their prescribing information, and emc icomply for Field Sales teams sharing product information with HCPs.
If your company is on emc, you may be able to benefit from pi portal or icomply – speak to your company’s Account Manager to learn more: Speak to my Datapharm Account Manager